Search results
Merck (MRK) Gets CHMP Nod for PAH Drug Winrevair in Europe
Zacks via Yahoo Singapore Finance· 15 hours agoWinrevair is the first novel activin signaling inhibitor approved by the FDA to treat PAH. Merck is...
Winrevair is the first novel activin signaling inhibitor approved by the FDA to treat PAH. Merck is...